期刊
SYNLETT
卷 27, 期 8, 页码 1145-1164出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0035-1561329
关键词
antitumor agents; cyclization; ene reaction; natural products; regioselectivity
资金
- NIH [GM104180]
- NSFGRFP [DGE-1346877]
- TSRI
- Eli Lilly
- Boehringer Ingelheim
- Amgen
- Baxter Foundation
- Sloan Foundation
The asmarine alkaloids constitute a small family of terpene-nucleobase marine metabolites defined by a unique N-hydroxy-diazepine pharmacophore that effects moderate to potent cytotoxicity against several cancer cell lines. Isolation of the metabolites from an unidentified producer organism provided enough material for initial assay, but this material was soon exhausted, impeding further study. Procurement of material through synthesis is the obvious solution. Here we chronicle our discovery of simple but potent asmarine analogues that solve the material supply problem. 1 Introduction 2 Project Selection 3 Project Design 3.1 The Big Picture 3.2 Synthetic Strategy 3.3 Challenges in the Design 4 The Quest to Find Bioactive Asmarines 4.1 Model Systems as Proof of Concepts 4.2 Stereoselectivity Investigation with Clerodane-Appended Cyclization Precursors 4.2.1 Obtaining the Cyclization Precursor 4.2.2 Results from Cyclization Screening 4.3 Toward the Synthesis of Asmarine A 4.4 A Turning Point: Screening Forward 5 Biological Investigation of the Asmarine Scaffold 5.1 Cytotoxicity Assays of our Synthetic Intermediates and their Enantiomers 5.2 Synthesis of Analogues for a More In-Depth Biological Investigation 6 Synthesis of Simple Asmarine Analogues and their Cytotoxicity 7 Conclusion
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据